Direct Costs for Care and Glycaemic Control in Patients with Type 2 Diabetes in Sudan

 

 Buy Article Permissions and Reprints

Abstract

The aim of this study was to estimate the contribution by type 2 diabetic patients in a low-income country from their own income in attempting to control the disease and to prevent chronic diabetes complications through good glycaemic control. Socio-economic and demographic data for study subjects were obtained from 822 adult diabetic patients attending public or private diabetic clinics in Khartoum State, Sudan. The average annual income of diabetic patients was estimated as USD 1.923. The direct cost of diabetes control was USD 175 per year. This included cost of drugs and ambulatory care, although drug supply was insufficient for 52% of the patients. Glycosylated hemoglobin as a measure of glycaemic control was determined to be unsatisfactory in 77% of patients. This gives an immediate indication that current practices in diabetes control in urban Sudan are not cost-effective. Patients attending private clinics had a higher income and cost of diabetes control than those attending public clinics. However, both groups had similar proportion of poor glycaemic control, which reflects the insufficient care given to diabetic patients, mainly due to deficient resources and inefficient utilization of what is scarcely available.

References

• 1 Abdelgadir M, Elbagir M, Eltom A. et al . Factors affecting perinatal morbidity and mortality in pregnancies complicated by diabetes mellitus in Sudan.  Diabetes Res Clin Pract. 2003;  60 41-47
  Google Scholar
• 2 Abdelgadir M, Elbagir M, Eltom M. et al . The influence of glucose self-monitoring on glycaemic control in patients with diabetes mellitus in Sudan.  Diabetes Res Clin Pract. 2006;  74 90-94
  Google Scholar
• 3 Chale SS, Swai AB, Mujinja PG. et al . Must diabetes be a fatal disease in Africa? Study of costs of treatment.  BMJ. 1992;  304 1215-1218
  Google Scholar
• 4 Chan BS, Tsang MW, Lee VW. et al . Cost of type 2 diabetes mellitus in Hong Kong Chinese.  Int J Clin Pharmacol Ther. 2007;  45 455-468
  Google Scholar
• 5 Elbagir MN, Eltom MA, Mahadi EO. et al . Pattern of long-term complications in Sudanese insulin-treated diabetic patients.  Diabetes Res Clin Pract. 1995a;  30 59-67
  Google Scholar
• 6 Elbagir MN, Eltom MA, Rosling H. et al . Glycaemic control of insulin-dependent diabetes mellitus in Sudan: Influence of insulin shortage.  Diabetes Res Clin Pract. 1995b;  30 43-52
  Google Scholar
• 7 Elbagir MN, Eltom MA, Elmahadi EM. et al . A population-based study of the prevalence of diabetes and impaired glucose tolerance in adults in northern Sudan.  Diabetes Care. 1996;  19 1126-1128
  Google Scholar
• 8 Elrayah H, Eltom M, Bedri A. et al . Economic burden on families of childhood type 1 diabetes in urban Sudan.  Diabetes Res Clin Pract. 2005;  70 159-165
  Google Scholar
• 9 Eltom M, Thompson C. Management of diabetes in Sudan.  Diabetes Form, Norwegian Diabetes Association. 2005;  2 32-34
  Google Scholar
• 10 Federal Ministry of Health, . Sudan. Sudan strategy plan.  2007; 
  Google Scholar
• 11 Habbani K, Groot W, Jelovac I. Household health-seeking behaviour in Khartoum, Sudan: The willingness to pay for public health services if these services are of good quality.  Health Policy. 2006;  75 140-158
  Google Scholar
• 12 Henriksson F, Jonsson B. Diabetes: The cost of illness in Sweden.  J Intern Med. 1998;  244 461-468
  Google Scholar
• 13 Henriksson F, Agardh CD, Berne C. et al . Direct medical costs for patients with type 2 diabetes in Sweden.  J Intern Med. 2000;  248 387-396
  Google Scholar
• 14 Jonsson B. Revealing the cost of type 2 diabetes in Europe.  Diabetologia. 2002;  45 S5-12
  Google Scholar
• 15 Redekop WK, Koopmanschap MA, Rutten GE. et al . Resource consumption and costs in Dutch patients with type 2 diabetes mellitus. Results from 29 general practices.  Diabet Med. 2002;  19 246-253
  Google Scholar
• 16 UK Prospective Diabetes Study group (UKPDS 33) . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes.  Lancet. 1998;  352 837-853
  Google Scholar
• 17 Wild S, Roglic G, Green A. et al . Global prevalence of diabetes: Estimates for the year 2000 and projections for 2 030.  Diabetes Care. 2004;  27 1047-1053
  Google Scholar

Correspondence

Prof. C.-G. Östenson

Department of Molecular

Medicine and Surgery

Karolinska Institutet

Karolinska University Hospital

17176 Stockholm

Sweden

Phone: +46-8-51776200

Fax: +46-8-51773096

Email: claes-goran.ostenson@ki.se